|European Case Law Identifier:||ECLI:EP:BA:2002:T119101.20020527|
|Date of decision:||27 May 2002|
|Case number:||T 1191/01|
|IPC class:||C12N 15/12|
|Language of proceedings:||EN|
|Download and more information:||
|Title of application:||Novel V28 seven transmembrane receptor|
|Applicant name:||ICOS CORPORATION|
|Opponent name:||SmithKline Beecham plc
Duphar International Research B.V.
|Relevant legal provisions:||
|Keywords:||Missing Statement of Grounds|
Summary of Facts and Submissions
I. The appeal contests the decision of the Opposition Division of the European Patent Office posted on 22. August 2001 revoking the European Patent No. 0 630 405.
The Appellant (patent proprietor) filed a notice of appeal by letter received on 30 October 2001 and paid the fee for appeal on the same date. No statement setting out the grounds of appeal was filed, and the notice of appeal contains nothing that could be regarded as a statement setting out the grounds of appeal pursuant to Article 108 EPC.
II. By a communication dated 14 February 2002, the Registry of the Board informed the Appellant that no statement setting out the grounds of appeal had been filed and that the appeal could be expected to be rejected as inadmissible. The Appellant was invited to file observations within two months. Attention was also drawn to Article 122 EPC.
III. No answer has been given to the Registry's communication.
Reasons for the Decision
As no written statement setting out the grounds of appeal has been filed, the appeal has to be rejected as inadmissible, Rule 65(1) EPC in conjunction with Article 108 EPC.
For these reasons it is decided that:
The appeal is rejected as inadmissible.